首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   922971篇
  免费   90332篇
  国内免费   313篇
  2018年   9764篇
  2017年   9412篇
  2016年   14353篇
  2015年   20638篇
  2014年   23083篇
  2013年   30507篇
  2012年   33855篇
  2011年   32154篇
  2010年   22310篇
  2009年   20723篇
  2008年   27594篇
  2007年   28494篇
  2006年   26747篇
  2005年   31697篇
  2004年   30360篇
  2003年   27660篇
  2002年   24348篇
  2001年   36410篇
  2000年   35371篇
  1999年   29369篇
  1998年   11305篇
  1997年   11055篇
  1996年   10533篇
  1995年   9718篇
  1994年   9433篇
  1993年   9445篇
  1992年   24283篇
  1991年   23763篇
  1990年   23201篇
  1989年   22643篇
  1988年   20899篇
  1987年   20046篇
  1986年   18641篇
  1985年   18567篇
  1984年   15267篇
  1983年   13217篇
  1982年   10136篇
  1981年   9171篇
  1980年   8535篇
  1979年   14174篇
  1978年   11204篇
  1977年   10039篇
  1976年   9637篇
  1975年   10787篇
  1974年   11606篇
  1973年   11438篇
  1972年   10453篇
  1971年   9407篇
  1970年   8224篇
  1969年   8111篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
7.
The alga Analipus japonicus (Harv.) Wynne displays a distinct seasonal pattern in its development in Peter the Great Bay (Sea of Japan). In winter and spring, it occurs only in the form of basal crusts, and vertical axes develop in the summer–autumn period. It reproduces mostly asexually from July to November. Algae with unilocular sporangia occur very seldom, only in June and July.  相似文献   
8.
Essential genes were identified in the 1.5-map unit dpy-5 unc-13 region of chromosome I in the Caenorhabditis elegans genome by rescuing lethal mutations using the duplication sDp2. In this paper, we report the mapping and complementation testing of lethal mutations, 45 of which identify 18 new, essential genes. This analysis brings the number of essential genes defined by the sDp2 rescue of lethal mutants to 97; 64 of these map between dpy-5 and unc-13. 61% of these essential genes are identified by more than one allele. Positioning of the mutations was done using the breakpoints of six duplications. The mutant phenotypes of 14 loci essential for fertility were characterized by Nomarski microscopy and DAPI staining. None of the mutants were rescued by wild-type male sperm. The cytological data showed that four genes produced mutants with defects in gonadogenesis, let-395, let-603, let-605 and let-610. Mutations in seven genes, let-355, let-367, let-384, let-513, let-544, let-545 and let-606, affected germ cell proliferation or gametogenesis. Mutants for the remaining three genes, let-370, let-599 and let-604, produced eggs that failed to develop or hatch, thereby acting as maternal effect lethals. We observed a nonrandom distribution of arrest phenotypes with regard to map position. Received: 8 May 1996 / Accepted : 27 January 1997  相似文献   
9.
10.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications) and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号